{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T01:32:36Z","timestamp":1769218356837,"version":"3.49.0"},"reference-count":18,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2020]]},"DOI":"10.1620\/tjem.250.153","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T22:03:41Z","timestamp":1583186621000},"page":"153-159","source":"Crossref","is-referenced-by-count":12,"title":["Better Retention of Abatacept Is Associated with High Rheumatoid Factor: A Five-Year Follow-Up Study of Patients with Rheumatoid Arthritis"],"prefix":"10.1620","volume":"250","author":[{"given":"Soshi","family":"Okazaki","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Osaki Citizen Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryu","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Osaki Citizen Hospital"},{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","unstructured":"Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., Felson, D.T., Bingham, C.O. 3rd, Birnbaum, N.S., Burmester, G.R., Bykerk, V.P., Cohen, M.D., Combe, B., Costenbader, K.H., Dougados, M., Emery, P., Ferraccioli, G., et al. (2010)  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.  <i>Ann. Rheum. Dis.<\/i>, 69, 1580-1588."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Ebina, K., Hashimoto, M., Yamamoto, W., Hirano, T., Hara, R., Katayama, M., Onishi, A., Nagai, K., Son, Y., Amuro, H., Yamamoto, K., Maeda, Y., Murata, K., Jinno, S., Takeuchi, T., et al. (2019)  Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis: the ANSWER cohort study.  <i>PLoS One<\/i>, 14, e0216624.","DOI":"10.1371\/journal.pone.0216624"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Endo, Y., Koga, T., Kawashiri, S.Y., Morimoto, S., Nishino, A., Okamoto, M., Eguchi, M., Tsuji, S., Takatani, A., Shimizu, T., Sumiyoshi, R., Igawa, T., Iwamoto, N., Ichinose, K., Tamai, M., et al. (2020)  Anti-citrullinated protein antibody titre as a predictor of abatacept treatment persistence in patients with rheumatoid arthritis: a prospective cohort study in Japan.  <i>Scand. J. Rheumatol.<\/i>, 49, 13-17.","DOI":"10.1080\/03009742.2019.1627411"},{"key":"4","unstructured":"Genovese, M.C., Becker, J.C., Schiff, M., Luggen, M., Sherrer, Y., Kremer, J., Birbara, C., Box, J., Natarajan, K., Nuamah, I., Li, T., Aranda, R., Hagerty, D.T. &amp; Dougados, M. (2005)  Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.  <i>N. Engl. J. Med.<\/i>, 353, 1114-1123."},{"key":"5","doi-asserted-by":"crossref","unstructured":"Harigai, M., Ishiguro, N., Inokuma, S., Mimori, T., Ryu, J., Takei, S., Takeuchi, T., Tanaka, Y., Takasaki, Y., Yamanaka, H., Yoshizawa, Y., Chinen, I., Nakao, T. &amp; Koike, T. (2019)  Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance.  <i>Mod. Rheumatol.<\/i>, 29, 747-755.","DOI":"10.1080\/14397595.2018.1524998"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Hirabayashi, Y., Munakata, Y., Miyata, M., Urata, Y., Saito, K., Okuno, H., Yoshida, M., Kodera, T., Watanabe, R., Miyamoto, S., Ishii, T., Nakazawa, S., Takemori, H., Ando, T., Kanno, T., et al. (2016)  Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: a multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group.  <i>Mod. Rheumatol.<\/i>, 26, 828-835.","DOI":"10.3109\/14397595.2016.1160991"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Ishizuka, M., Watanabe, R., Ishii, T., Machiyama, T., Akita, K., Fujita, Y., Shirota, Y., Fujii, H. &amp; Harigae, H. (2016)  Long-term follow-up of 124 patients with polymyositis and dermatomyositis: statistical analysis of prognostic factors.  <i>Mod. Rheumatol.<\/i>, 26, 115-120.","DOI":"10.3109\/14397595.2015.1054081"},{"key":"8","unstructured":"Kanda, Y. (2013)  Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics.  <i>Bone Marrow Transplant.<\/i>, 48, 452-458."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Koga, T., Okada, A., Fukuda, T., Hidaka, T., Ishii, T., Ueki, Y., Kodera, T., Nakashima, M., Takahashi, Y., Honda, S., Horai, Y., Watanabe, R., Okuno, H., Aramaki, T., Izumiyama, T., et al. (2017)  Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: a post hoc analysis of a nationwide cohort in Japan.  <i>PLoS One<\/i>, 12, e0175281.","DOI":"10.1371\/journal.pone.0175281"},{"key":"10","unstructured":"Kondo, H., Watanabe, R., Okazaki, S., Kuriyama, K., Harigae, H. &amp; Fujii, H. (2019)  Coexistence of rheumatoid arthritis and systemic lupus erythematosus is still rare in the biologic era: report of seven cases and literature review.  <i>Mod. Rheumatol.<\/i>, doi: 10.1080\/14397595.1682795. [Epub ahead of print]."},{"key":"11","unstructured":"Kubo, S., Nakano, K., Nakayamada, S., Hirata, S., Fukuyo, S., Sawamukai, N., Saito, K. &amp; Tanaka, Y. (2016)  Clinical, radiographic and functional efficacy of abatacept in routine care for rheumatoid arthritis patients: Abatacept Leading Trial for RA on Imaging Remission (ALTAIR) study.  <i>Clin. Exp. Rheumatol.<\/i>, 34, 834-841."},{"key":"12","unstructured":"Kubo, S., Nakayamada, S., Nakano, K., Sawamukai, N., Hirata, S., Hanami, K., Saito, K. &amp; Tanaka, Y. (2018)  Comparison of efficacy of TNF inhibitors and abatacept in patients with rheumatoid arthritis; adjusted with propensity score matching.  <i>Clin. Immunol.<\/i>, 191, 67-74."},{"key":"13","unstructured":"Linsley, P.S., Brady, W., Urnes, M., Grosmaire, L.S., Damle, N.K. &amp; Ledbetter, J.A. (1991)  CTLA-4 is a second receptor for the B cell activation antigen B7.  <i>J. Exp. Med.<\/i>, 174, 561-569."},{"key":"14","doi-asserted-by":"crossref","unstructured":"Smolen, J.S., Aletaha, D. &amp; McInnes, I.B. (2016)  Rheumatoid arthritis.  <i>Lancet<\/i>, 388, 2023-2038.","DOI":"10.1016\/S0140-6736(16)30173-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Smolen, J.S., Landewe, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., Aletaha, D., Aringer, M., Boers, M., Buckley, C.D., Buttgereit, F., et al. (2017)  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.  <i>Ann. Rheum. Dis.<\/i>, 76, 960-977.","DOI":"10.1136\/annrheumdis-2016-210715"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Sokolove, J., Schiff, M., Fleischmann, R., Weinblatt, M.E., Connolly, S.E., Johnsen, A., Zhu, J., Maldonado, M.A., Patel, S. &amp; Robinson, W.H. (2016)  Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial.  <i>Ann. Rheum. Dis.<\/i>, 75, 709-714.","DOI":"10.1136\/annrheumdis-2015-207942"},{"key":"17","unstructured":"Tomiyama, F., Watanabe, R., Ishii, T., Kamogawa, Y., Fujita, Y., Shirota, Y., Sugimura, K., Fujii, H. &amp; Harigae, H. (2016)  High prevalence of acute exacerbation of interstitial lung disease in Japanese patients with systemic sclerosis.  <i>Tohoku J. Exp. Med.<\/i>, 239, 297-305."},{"key":"18","unstructured":"Yoshida, M., Watanabe, R., Ishii, T., Machiyama, T., Akita, K., Fujita, Y., Shirota, Y., Sugimura, K., Fujii, H., Shimokawa, H. &amp; Harigae, H. (2016)  Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience.  <i>Int. J. Rheum. Dis.<\/i>, 19, 87-94."}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/250\/3\/250_153\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T03:17:28Z","timestamp":1583551048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/250\/3\/250_153\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.250.153","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}